Company Filing History:
7 out of 54 
7 out of 13 Years Active: 2013-2020
Title: Paul Cales - Innovator in Liver Fibrosis Assessment and Treatment
Introduction
Paul Cales is a distinguished inventor based in Avrille, France. With a remarkable portfolio of 7 patents, Cales focuses on innovative methods for assessing and treating liver fibrosis. His contributions to medical technology have significant implications for patient care and treatment protocols.
Latest Patents
Cales' latest patented inventions include:
1. **Non-invasive Method for Assessing Liver Fibrosis Progression** - This groundbreaking method assesses liver fibrosis progression in individuals, classifying them as slow, medium, or fast fibroser. Furthermore, it delineates a treatment approach for fast fibrosers, ensuring timely administration of at least one therapeutic agent aimed at treating either liver fibrosis or its underlying cause.
2. **Automatic Measurement of Lesions on Medical Images** - This invention provides a method for evaluating the presence and severity of lesions in organs or tissues through automated image analysis. Specifically targeting liver tissues, this method entails measuring multiple image descriptors, mathematically combining them into a score, and using that score to assess any lesions' presence or severity.
Career Highlights
Throughout his career, Paul Cales has contributed his expertise to significant institutions such as the Centre Hospitalier Universitaire d'Angers and Université d'Angers. His work in these institutions emphasizes his commitment to advancing medical research and technology.
Collaborations
Cales has collaborated with notable coworkers, including Gilles Hunault and Julien Chaigneau. These partnerships have likely enriched his inventions through shared knowledge and diverse perspectives within the field.
Conclusion
Paul Cales stands out as a pivotal figure in medical innovation, particularly concerning liver fibrosis. His patented methods not only enhance diagnostic techniques but also improve treatment strategies for affected individuals. Through his dedicated work and collaborations, Cales continues to make significant strides in the field of medical technology.